Navin Fluorine International Ltd vs Saroja Pharma Industries India Ltd Stock Comparison
Navin Fluorine International Ltd vs Saroja Pharma Industries India Ltd Stock Comparison
Last Updated on: Mar 23, 2026
Key Highlights
The Latest Trading Price of Navin Fluorine International Ltd is ₹ 5884 as of 23 Mar 15:30
. The P/E Ratio of Navin Fluorine International Ltd changed from 52.9 on March 2021 to 72.3 on March 2025 . This represents a CAGR of 6.45% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Navin Fluorine International Ltd changed from ₹ 13613 crore on March 2021 to ₹ 20871 crore on March 2025 . This represents a CAGR of 8.92% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Navin Fluorine International Ltd for the Dec '25 is ₹ 907.95 crore as compare to the Sep '25 revenue of ₹ 776.63 crore. This represent the growth of 16.91% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Navin Fluorine International Ltd for the Dec '25 is ₹ 302.68 crore as compare to the Sep '25 ebitda of ₹ 264.38 crore. This represent the growth of 14.49% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Navin Fluorine International Ltd changed from ₹ 51.2 crore to ₹ 185.4 crore over 7 quarters. This represents a CAGR of 108.61%
The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0%
The Dividend Payout of Navin Fluorine International Ltd changed from 18.2 % on March 2021 to 14.35 % on March 2025 . This represents a CAGR of -4.64% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About Navin Fluorine International Ltd
Navin Fluorine International Limited was incorporated on June 25, 1998.
AS a flagship, Company belongs to a reputed industrial house of Padmanabh Mafatlal Group in India.
It has largest integrated fluorochemicals complex in India, since 1967.
The Company primarily focuses on fluorine chemistry - producing refrigeration gases, chemicals, inorganic bulk fluorides, specialty organofluorines and offers Contract Research and manufacturing services.
The Company's manufacturing unit was located in Surat.
About Saroja Pharma Industries India Ltd
Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023.
Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business.
In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.
FAQs for the comparison of Navin Fluorine International Ltd and Saroja Pharma Industries India Ltd
Which company has a larger market capitalization, Navin Fluorine International Ltd or Saroja Pharma Industries India Ltd?
Market cap of Navin Fluorine International Ltd is 31,390 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr
What are the key factors driving the stock performance of Navin Fluorine International Ltd and Saroja Pharma Industries India Ltd?
The stock performance of Navin Fluorine International Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Navin Fluorine International Ltd and Saroja Pharma Industries India Ltd?
As of March 23, 2026, the Navin Fluorine International Ltd stock price is INR ₹6124.55. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹28.15.
How do dividend payouts of Navin Fluorine International Ltd and Saroja Pharma Industries India Ltd compare?
To compare the dividend payouts of Navin Fluorine International Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.